We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ADDV-B.ST

Price
1.61
Stock movement down
-0.04 (-2.48%)
Company name
ADDvise Group B
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Medical Instruments & Supplies
Markedsværdi
916.80M
Ent værdi
3.23B
Pris/omsætning
0.56
Pris/bog
1.17
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
8.01
Fremtidig P/E
5.73
PEG
-
EPS-vekst
-
1 års afkast
-79.53%
3 års afkast
-38.54%
5 års afkast
10.14%
10 års afkast
-
Senest opdateret: 2025-08-27

UDBYTTE

ADDV-B.ST betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E8.01
Pris til OCF14.33
Pris til FCF50.37
Pris til EBITDA2.59
EV i forhold til EBITDA9.14

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning0.56
Pris til egenkapital1.17
EV i forhold til salg1.99

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier583.21M
EPS (TTM)0.58
FCF pr. aktie (TTM)0.09

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)1.63B
Bruttofortjeneste (TTM)409.70M
Driftsindkomst (TTM)264.10M
Nettoindkomst (TTM)114.40M
EPS (TTM)0.58
EPS (1 år frem)0.27

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)25.19%
Driftsmargin (TTM)16.24%
Fortjenstmargin (TTM)7.03%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter278.10M
Nettotilgodehavender391.90M
Omsætningsaktiver i alt921.90M
Goodwill1.53B
Immaterielle aktiver711.70M
Ejendomme, anlæg og udstyr0.00
Sum aktiver3.37B
Kreditor116.60M
Kortfristet/nuværende langsigtet gæld1.73B
Summen af kortfristede forpligtelser566.40M
Sum gæld2.59B
Aktionærernes egenkapital782.00M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)64.00M
Investeringsudgifter (TTM)45.80M
Fri pengestrøm (TTM)18.20M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast14.63%
Afkast af aktiver3.39%
Afkast af investeret kapital13.10%
Kontant afkast af investeret kapital2.08%

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning1.61
Daglig høj1.61
Daglig lav1.55
Daglig volumen766K
Højeste gennem alle tider16.82
1 års analytiker estimat2.50
Beta-0.11
EPS (TTM)0.58
Udbytte pr. aktie-
Ex-div dato26 Apr 2021
Næste dato for resultatpræsentation23 Oct 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
ADDV-B.STS&P500
Nuværende prisfald fra top notering-90.42%-2.53%
Højeste prisfald-93.52%-56.47%
Højeste efterår dato9 Apr 20259 Mar 2009
Gennemsnitlig fald fra toppen-50.67%-11.04%
Gennemsnitlig tid til nyt højdepunkt49 days12 days
Maks. tid til nyt højdepunkt1484 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
ADDV-B.ST (ADDvise Group B) company logo
Markedsværdi
916.80M
Markedsværdi kategori
Small-cap
Beskrivelse
ADDvise Group AB (publ) supplies medical devices, equipment, and consumables to public and private laboratories and research facilities, healthcare, and pharmaceuticals in North America, Europe, South America, Sweden, and internationally. The company provides laboratory furniture, protective ventilation systems, climate-controlled clean rooms, and laboratory equipment; and develops and supplies medical equipment, consumables, and pharmaceuticals in areas, such as urology, gynecology, emergency care, and surgery. It is also involved in rental and sale of medical equipment; distributes specialized instruments, consumables, and services in the life-science and biopharma sectors; designing, constructing, and installing customized cleanrooms and air conditioning systems; distributes glucose monitors and insulin pumps for diabetic patients; develops, manufactures, and markets products for rescue, ambulance, healthcare, and rehabilitation operations. In addition, the company offers implants, instruments, and technologies for surgical precision and patient; disposable medical devices, cables, connectors, wires, CO2 indicators, ultrasound device, patient positioning equipment, and surgical tables; develops software and instruments for patient mobility, pain, and muscle strength to rehabilitate muscular conditions, as well as to streamline the monitoring of vital signs in patients in long-term care and nursing homes; operates mail-order pharmacy specializing in men's health medications for treating cancer, incontinence, and impotence; develops, manufactures, and markets over-the-counter generic drugs for pain management and for the treatment of coughs, colds, allergies, sinus infections, and urological conditions; and supplies glucose meter and test strip products. The company was formerly known as ADDvise Lab Solutions AB (publ). ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.
Personale
605
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Sweden
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
ADDvise Group AB (FRA:Q3I) reports robust cash flow and strategic debt reduction, despite facing currency headwinds and CapEx cycle softness.
18. juli 2025
Despite revenue growth and a successful rights issue, ADDvise Group AB faces margin pressures and macroeconomic uncertainties.
10. maj 2025
ADDvise Group AB (FRA:Q3I) reports an 11% increase in net sales, while addressing organic growth hurdles and strategic shifts in its healthcare and lab segments.
21. februar 2025